Stock CZMWF CARL ZEISS MEDITEC AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Carl Zeiss Meditec AG OTC Markets

Equities

CZMWF

DE0005313704

Market Closed - OTC Markets
Other stock markets
 11:25:34 2024-06-24 EDT 		5-day change 1st Jan Change
72.65 USD +3.83% Intraday chart for Carl Zeiss Meditec AG +1.71% -32.28%
06-24 RBC lowers target for Carl Zeiss Meditec to 85 euros - 'Outperform' DP
06-24 UBS lowers Carl Zeiss Meditec to 'Neutral' - target to 71 euros DP

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • The company's earnings growth outlook lacks momentum and is a weakness.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 30.03 times its estimated earnings per share for the ongoing year.
  • The company is highly valued given the cash flows generated by its activity.
  • The company is not the most generous with respect to shareholders' compensation.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • For the last few months, analysts have been revising downwards their earnings forecast.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
CARL ZEISS MEDITEC AG Stock Carl Zeiss Meditec AG
-32.28% 6.32B -
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+4.85% 212B
B
DANAHER CORPORATION Stock Danaher Corporation
+9.86% 188B
B-
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+31.11% 157B
B-
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+34.08% 114B
A-
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+2.85% 64.01B
A-
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+1.63% 48.83B
B+
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-3.12% 39.3B
A
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+1.93% 35.97B -
RESMED, INC. Stock ResMed, Inc.
+6.87% 27B
B+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. AFX Stock
  4. CZMWF Stock
  5. Ratings Carl Zeiss Meditec AG